Literature DB >> 11527806

Slow human immunodeficiency virus (HIV) infectivity correlated with low HIV coreceptor levels.

C L Bristow1.   

Abstract

The absolute number of CD4+ lymphocytes in blood is prognostic for disease progression, yet the cell surface density of CD4 receptors or chemokine receptors on a single cell has not previously been found to be predictive of human immunodeficiency virus (HIV) infectivity outcome. It has recently been shown that human leukocyte elastase (HLE) and its ligand alpha(1) proteinase inhibitor (alpha(1)PI; alpha(1)antitrypsin) act as HIV fusion cofactors. The present study shows that decreased HIV infectivity is significantly correlated with decreased cell surface density of HLE but not with decreased CD4 nor chemokine receptors. In vitro HIV infectivity outcome in this study was predicted by the surface density of HLE on mononuclear phagocytes but not on lymphocytes. The set point HLE surface density was in part determined by alpha(1)PI. Decreased circulating alpha(1)PI was correlated with increased cell surface HLE and with increased HIV infectivity. The correlation of HIV infectivity outcome with surface HLE and circulating alpha(1)PI supports the utility of these HIV cofactors in diagnostic analysis and therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11527806      PMCID: PMC96174          DOI: 10.1128/CDLI.8.5.932-936.2001

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  7 in total

Review 1.  Protease inhibitors of human plasma. Alpha 1-antitrypsin.

Authors:  R W Berninger
Journal:  J Med       Date:  1985

2.  Self antigen prognostic for human immunodeficiency virus disease progression.

Authors:  C L Bristow; H Patel; R R Arnold
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

3.  Alpha-1-antitrypsin inhibits human immunodeficiency virus type 1.

Authors:  L Shapiro; G B Pott; A H Ralston
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

4.  Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Authors:  C L Bristow; F Di Meo; R R Arnold
Journal:  Clin Immunol Immunopathol       Date:  1998-12

5.  Quantitation of human immunodeficiency virus type 1 infection kinetics.

Authors:  D S Dimitrov; R L Willey; H Sato; L J Chang; R Blumenthal; M A Martin
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

6.  Inhibition of HIV-1 by modification of a host membrane protease.

Authors:  C L Bristow; S A Fiscus; P M Flood; R R Arnold
Journal:  Int Immunol       Date:  1995-02       Impact factor: 4.823

7.  Expression and processing of the AIDS virus reverse transcriptase in Escherichia coli.

Authors:  W G Farmerie; D D Loeb; N C Casavant; C A Hutchison; M H Edgell; R Swanstrom
Journal:  Science       Date:  1987-04-17       Impact factor: 47.728

  7 in total
  1 in total

1.  Self antigen prognostic for human immunodeficiency virus disease progression.

Authors:  C L Bristow; H Patel; R R Arnold
Journal:  Clin Diagn Lab Immunol       Date:  2001-09
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.